Drug repurposing for stroke intervention

被引:18
|
作者
Ghosh, Debarati [1 ]
Sehgal, Karan [1 ]
Sodnar, Babasaheb [1 ]
Bhosale, Nikhil [1 ]
Sarmah, Deepaneeta [1 ]
Datta, Aishika [1 ]
Chaudhary, Antra [1 ]
Kalia, Kiran [1 ]
Wang, Xin [2 ]
Bhattacharya, Pallab [1 ]
机构
[1] Natl Inst Pharmaceut Educ & Res NIPER, Dept Pharmacol & Toxicol, Gandhinagar, Ahmadabad, Gujarat, India
[2] Brigham & Womens Hosp, Harvard Med Sch, Dept Neurosurg, Boston, MA 02115 USA
关键词
Ischemic stroke; Drug repurposing; Conventional therapy; Recombinant-tissue plasminogen activator; Mechanical thrombectomy; Drug development; INHIBITORS; PREVENTION; COLCHICINE; MECHANISM; STATINS; DESIGN; TARGET;
D O I
10.1016/j.drudis.2022.03.003
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Despite the availability of advanced interventions, stroke remains one of the most significant causes of mortality and morbidity worldwide. US Food and Drug Administration (FDA)-approved treatment options for stroke include tissue plasminogen activators (tPAs) and mechanical thrombectomy (MT). However, these are limited by a narrow therapeutic time window. Additionally, poststroke rehabilitation therapies can provide functional recovery but take a long time to show benefits. Drug repurposing could be a novel approach to broaden treatment options in this scenario. In this review, we summarize marketed drugs that could be repurposed based on their safety and efficacy data. We also briefly discuss their mechanisms of action and provide a list of repurposed drugs under trials for ischemic stroke therapy.
引用
收藏
页码:1974 / 1982
页数:9
相关论文
共 50 条
  • [31] A bibliometric review of drug repurposing
    Baker, Nancy C.
    Ekins, Sean
    Williams, Antony J.
    Tropsha, Alexander
    DRUG DISCOVERY TODAY, 2018, 23 (03) : 661 - 672
  • [32] Drug repurposing for antimicrobial discovery
    Maya A. Farha
    Eric D. Brown
    Nature Microbiology, 2019, 4 : 565 - 577
  • [33] Drug repurposing in kidney disease
    Panchapakesan, Usha
    Pollock, Carol
    KIDNEY INTERNATIONAL, 2018, 94 (01) : 40 - 48
  • [34] Drug repurposing with network reinforcement
    Yonghyun Nam
    Myungjun Kim
    Hang-Seok Chang
    Hyunjung Shin
    BMC Bioinformatics, 20
  • [35] Drug Repurposing in Cancer Care
    Bowden, Nikola A.
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2024, 20 : 71 - 71
  • [36] Repurposing Niacin as Antiplatelet Drug?
    Mangoni, Arduino A.
    CURRENT CLINICAL PHARMACOLOGY, 2016, 11 (01): : 2 - +
  • [37] Drug Repurposing for Rare Diseases
    Roessler, Helen, I
    Knoers, Nine V. A. M.
    van Haelst, Mieke M.
    van Haaften, Gijs
    TRENDS IN PHARMACOLOGICAL SCIENCES, 2021, 42 (04) : 255 - 267
  • [38] Drug Repurposing in Human Cancers
    Grassi, Gabriele
    Grassi, Mario
    CURRENT MEDICINAL CHEMISTRY, 2020, 27 (42) : 7213 - 7213
  • [39] Recycled Translation: Repurposing Drugs for Stroke
    Spellicy, Samantha E.
    Hess, David C.
    TRANSLATIONAL STROKE RESEARCH, 2022, 13 (06) : 866 - 880
  • [40] Bioinformatics Perspective of Drug Repurposing
    Patel, Binita
    Gelat, Brijesh
    Soni, Mehul
    Rathaur, Pooja
    Johar, S. R. Kaid
    CURRENT BIOINFORMATICS, 2024, 19 (04) : 295 - 315